wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42175048-1F75582D-8C1D-48D3-B395-EE4869B21DE6
Q42175048-1F75582D-8C1D-48D3-B395-EE4869B21DE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42175048-1F75582D-8C1D-48D3-B395-EE4869B21DE6
Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B.
P2860
Q42175048-1F75582D-8C1D-48D3-B395-EE4869B21DE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42175048-1F75582D-8C1D-48D3-B395-EE4869B21DE6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7774979149571c7a0b88884d5103d484cee8d966
P2860
Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks.